Complete Filing Data
Aura Biosciences, Inc. reported Stockholders Equity of $136.91 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Aura Biosciences, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$106.2M | -$86.9M | -$76.4M | -$58.8M | -$35.3M | -$22.2M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$179.0K | -$271.0K | $611.0K | -$72.0K | ||
| Research And Development Expense | $90.3M | $73.3M | $65.2M | $42.2M | $25.2M | $18.0M |
| Operating Income Loss | -$112.8M | -$96.1M | -$85.0M | -$60.3M | -$35.3M | -$22.2M |
| General And Administrative Expense | $22.5M | $22.8M | $19.8M | $18.1M | $10.1M | $4.2M |
| Interest Income Expense After Provision For Loan Loss | $6.6M | $9.4M | $8.6M | $1.9M | $13.0K | -$3.0K |
| Nonoperating Income Expense | $6.7M | $9.3M | $8.7M | $1.5M | -$1.0K | |
| Comprehensive Income Net Of Tax | -$106.6M | -$87.2M | -$75.8M | -$58.8M | -$35.3M | |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$365.0K | -$276.0K | $611.0K | -$72.0K | ||
| Other Nonoperating Income Expense | $77.0K | -$120.0K | -$76.0K | -$14.0K | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$106.1M | -$86.8M | -$76.3M | -$58.8M | ||
| Marketable Securities Gain Loss Excluding Other Than Temporary Impairments | $1.5M | $4.7M | $4.0M | $527.0K | ||
| Income Tax Expense Benefit | $108.0K | $112.0K | $137.0K | $0.00 | ||
| Net Income Loss Available To Common Stockholders Basic And Diluted | -$58.8M | -$46.2M | -$30.1M | |||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$186.0K | -$5.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$26.1M | -$27.0M | -$27.5M | -$21.0M | -$20.3M | -$19.7M | -$18.5M | -$18.3M | -$17.5M | -$15.9M | -$13.5M | -$12.8M | -$8.8M | -$8.9M | -$5.9M | -$3.6M | -$6.2M | -$7.5M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $57.0K | -$88.0K | -$137.0K | $790.0K | -$201.0K | -$521.0K | $89.0K | -$178.0K | $27.0K | -$19.0K | -$123.0K | -$5.0K | ||||||
| Research And Development Expense | $22.2M | $22.9M | $23.3M | $17.0M | $16.9M | $17.1M | $15.4M | $15.1M | $14.4M | $11.3M | $9.5M | $8.3M | $6.4M | $6.6M | $4.2M | $2.9M | ||
| Operating Income Loss | -$27.9M | -$28.6M | -$29.0M | -$23.2M | -$22.8M | -$22.3M | -$20.5M | -$20.3M | -$19.4M | -$16.1M | -$13.8M | -$12.8M | -$8.9M | -$8.8M | -$5.9M | -$3.6M | ||
| General And Administrative Expense | $5.7M | $5.7M | $5.7M | $6.2M | $5.9M | $5.3M | $5.1M | $5.2M | $5.0M | $4.8M | $4.3M | $4.5M | $2.5M | $2.2M | $1.7M | $781.0K | ||
| Interest Income Expense After Provision For Loan Loss | $1.8M | $1.7M | $1.6M | $2.3M | $2.5M | $2.7M | $2.0M | $2.0M | $2.0M | $483.0K | $292.0K | $25.0K | $5.0K | $4.0K | -$1.0K | |||
| Nonoperating Income Expense | $1.8M | $1.6M | $1.6M | $2.2M | $2.4M | $2.7M | $2.0M | $2.0M | $2.0M | $154.0K | $348.0K | -$24.0K | $57.0K | -$51.0K | ||||
| Comprehensive Income Net Of Tax | -$26.1M | -$27.1M | -$27.6M | -$20.3M | -$20.5M | -$20.2M | -$18.4M | -$18.5M | -$17.4M | -$15.9M | -$13.6M | -$12.8M | -$8.8M | -$8.9M | -$8.3M | |||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $44.0K | -$80.0K | -$158.0K | $790.0K | -$201.0K | -$521.0K | $89.0K | -$178.0K | $27.0K | -$19.0K | -$123.0K | -$5.0K | ||||||
| Other Nonoperating Income Expense | -$13.0K | -$36.0K | -$24.0K | -$25.0K | -$26.0K | -$32.0K | -$5.0K | -$32.0K | -$13.0K | -$329.0K | $56.0K | -$44.0K | $52.0K | |||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$26.1M | -$27.0M | -$27.5M | -$21.0M | -$20.3M | -$19.7M | -$18.5M | -$18.3M | -$17.5M | |||||||||
| Marketable Securities Gain Loss Excluding Other Than Temporary Impairments | $501.0K | $1.5M | $1.0M | $5.0K | ||||||||||||||
| Income Tax Expense Benefit | $26.0K | $48.0K | $18.0K | $43.0K | $46.0K | $0.00 | ||||||||||||
| Net Income Loss Available To Common Stockholders Basic And Diluted | -$15.9M | -$13.5M | -$12.8M | -$12.5M | -$12.5M | -$8.3M | -$5.6M | |||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$13.0K | $8.0K | -$21.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $136.9M | $152.0M | $225.8M | $195.6M | $152.3M | -$108.7M | -$87.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $60.3M | $32.5M | $41.9M | $122.4M | $149.2M | $17.5M | $32.5M |
| Restricted Cash And Cash Equivalents Noncurrent | $768.0K | $768.0K | $768.0K | $768.0K | $125.0K | $75.0K | |
| Cash And Cash Equivalents At Carrying Value | $59.5M | $31.7M | $41.1M | $121.6M | $149.1M | $17.4M | |
| Restricted Cash And Cash Equivalents At Carrying Value | $0.00 | $19.0K | $20.0K | $23.0K | $19.0K | ||
| Retained Earnings Accumulated Deficit | -$480.4M | -$374.2M | -$287.3M | -$210.9M | -$152.1M | -$116.9M | |
| Property Plant And Equipment Net | $2.6M | $3.2M | $3.2M | $5.4M | $5.3M | $3.6M | |
| Prepaid Expense And Other Assets Current | $5.5M | $9.5M | $5.6M | $7.9M | $4.6M | $1.0M | |
| Liabilities Current | $18.4M | $14.9M | $12.4M | $10.5M | $7.4M | $2.7M | |
| Liabilities And Stockholders Equity | $169.4M | $182.5M | $255.1M | $223.9M | $160.0M | $22.1M | |
| Liabilities | $32.5M | $30.5M | $29.2M | $28.4M | $7.7M | $2.7M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $60.3M | $32.5M | $41.9M | $122.4M | $149.2M | $17.5M | |
| Assets Current | $149.7M | $160.6M | $231.8M | $196.7M | $153.7M | $18.5M | |
| Assets | $169.4M | $182.5M | $255.1M | $223.9M | $160.0M | $22.1M | |
| Accrued Expenses And Other Current Liabilities | $13.6M | $9.5M | $7.9M | $4.6M | $4.3M | $2.1M | |
| Accounts Payable Current | $1.5M | $2.3M | $1.8M | $2.9M | $2.4M | $611.0K | |
| Operating Lease Right Of Use Asset | $15.8M | $17.4M | $18.9M | $20.7M | $950.0K | ||
| Operating Lease Liability Noncurrent | $14.1M | $15.6M | $16.9M | $17.9M | $360.0K | ||
| Operating Lease Liability Current | $3.2M | $3.1M | $2.7M | $3.0M | $615.0K | ||
| Marketable Securities | $84.7M | $119.4M | $185.1M | $67.2M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$9.4M | -$80.5M | -$26.8M | $131.7M | -$15.1M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$102.0K | $263.0K | $539.0K | -$72.0K | |||
| Other Assets Noncurrent | $471.0K | $518.0K | $509.0K | $423.0K | |||
| Non Cash Lease Expense | $1.6M | $1.5M | $1.8M | $968.0K | |||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | -$208.0K | $22.0K | -$3.0K | |||
| Other Operating Activities Cash Flow Statement | -$5.0K | $224.0K | $15.0K | ||||
| Initial Measurement Of Right Of Use Assets And Lease Liabilities For Operating Lease | $536.0K | ||||||
| Warrant Liability Noncurrent | $72.0K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $28.0M | -$9.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $156.7M | $174.6M | $128.0M | $174.7M | $191.5M | $208.8M | $151.7M | $166.4M | $180.3M | $115.1M | $129.1M | $141.1M | -$131.0M | -$122.8M | -$114.2M | -$104.0M | -$100.6M | -$94.7M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $48.3M | $108.1M | $39.0M | $26.2M | $30.8M | $27.0M | $56.4M | $48.5M | $39.3M | $62.1M | $54.8M | $108.5M | $82.0M | $92.4M | $99.8M | $16.2M | |||
| Restricted Cash And Cash Equivalents Noncurrent | $768.0K | $768.0K | $768.0K | $768.0K | $768.0K | $768.0K | $768.0K | $768.0K | $768.0K | $768.0K | $893.0K | $125.0K | $125.0K | $125.0K | $75.0K | $75.0K | |||
| Cash And Cash Equivalents At Carrying Value | $47.6M | $107.4M | $38.2M | $25.4M | $30.1M | $26.3M | $55.6M | $47.7M | $38.5M | $61.1M | $53.8M | $108.4M | $81.8M | $92.2M | $99.7M | $11.3M | |||
| Restricted Cash And Cash Equivalents At Carrying Value | $0.00 | $0.00 | $0.00 | $20.0K | $20.0K | $20.0K | $182.0K | $28.0K | $23.0K | $20.0K | $31.0K | $19.0K | $4.9M | ||||||
| Retained Earnings Accumulated Deficit | -$454.9M | -$428.7M | -$401.7M | -$348.4M | -$327.4M | -$307.0M | -$265.2M | -$246.7M | -$228.4M | -$194.3M | -$178.4M | -$165.0M | -$140.5M | ||||||
| Property Plant And Equipment Net | $2.6M | $2.9M | $3.1M | $3.3M | $3.3M | $3.1M | $4.9M | $5.1M | $5.2M | $5.5M | $5.8M | $5.9M | $4.4M | ||||||
| Prepaid Expense And Other Assets Current | $8.3M | $6.6M | $6.5M | $9.1M | $8.2M | $9.4M | $4.8M | $4.2M | $5.6M | $4.2M | $5.5M | $6.3M | $1.6M | ||||||
| Liabilities Current | $18.8M | $14.9M | $12.2M | $14.7M | $10.5M | $9.7M | $10.9M | $8.9M | $8.1M | $10.0M | $5.8M | $5.0M | $5.8M | ||||||
| Liabilities And Stockholders Equity | $190.0M | $204.4M | $155.4M | $205.3M | $218.3M | $235.0M | $179.8M | $192.7M | $206.0M | $143.1M | $135.0M | $146.4M | $90.7M | ||||||
| Liabilities | $33.4M | $29.8M | $27.4M | $30.7M | $26.8M | $26.2M | $28.0M | $26.3M | $25.8M | $28.1M | $5.9M | $5.3M | $6.4M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $48.3M | $108.1M | $39.0M | $26.2M | $30.8M | $27.0M | $56.4M | $48.5M | $39.3M | $62.1M | $54.8M | $108.5M | $82.0M | $92.4M | $99.8M | $16.2M | |||
| Assets Current | $170.1M | $184.0M | $134.5M | $183.5M | $195.6M | $212.2M | $153.9M | $166.2M | $179.1M | $115.9M | $127.7M | $139.6M | $83.5M | ||||||
| Assets | $190.0M | $204.4M | $155.4M | $205.3M | $218.3M | $235.0M | $179.8M | $192.7M | $206.0M | $143.1M | $135.0M | $146.4M | $90.7M | ||||||
| Accrued Expenses And Other Current Liabilities | $13.7M | $10.4M | $7.0M | $9.6M | $6.3M | $5.0M | $6.4M | $5.3M | $4.1M | $5.3M | $4.0M | $2.4M | $3.5M | ||||||
| Accounts Payable Current | $1.9M | $1.3M | $2.0M | $2.0M | $1.5M | $1.9M | $1.5M | $553.0K | $1.1M | $1.7M | $1.2M | $2.0M | $1.7M | ||||||
| Operating Lease Right Of Use Asset | $16.2M | $16.6M | $17.0M | $17.7M | $18.1M | $18.5M | $19.6M | $20.0M | $20.3M | $21.0M | $656.0K | $804.0K | $1.1M | ||||||
| Operating Lease Liability Noncurrent | $14.5M | $14.9M | $15.3M | $16.0M | $16.3M | $16.6M | $17.2M | $17.4M | $17.7M | $18.1M | $51.0K | $206.0K | $513.0K | ||||||
| Operating Lease Liability Current | $3.2M | $3.2M | $3.2M | $3.1M | $2.8M | $2.7M | $3.0M | $3.0M | $3.0M | $2.9M | $633.0K | $624.0K | $607.0K | ||||||
| Marketable Securities | $114.3M | $69.9M | $89.8M | $149.0M | $157.3M | $176.6M | $93.5M | $114.3M | $135.0M | $50.4M | $68.3M | $24.9M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$14.8M | -$83.1M | -$40.7M | $82.3M | |||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $69.0K | $25.0K | $105.0K | $607.0K | -$183.0K | $18.0K | -$134.0K | -$223.0K | -$45.0K | -$147.0K | -$128.0K | -$5.0K | |||||||
| Other Assets Noncurrent | $277.0K | $185.0K | $0.00 | $22.0K | $443.0K | $453.0K | $685.0K | $700.0K | $623.0K | ||||||||||
| Non Cash Lease Expense | $374.0K | $353.0K | $331.0K | ||||||||||||||||
| Gain Loss On Sale Of Property Plant Equipment | -$313.0K | $5.0K | -$3.0K | ||||||||||||||||
| Other Operating Activities Cash Flow Statement | $27.0K | -$5.0K | $0.00 | $46.0K | |||||||||||||||
| Initial Measurement Of Right Of Use Assets And Lease Liabilities For Operating Lease | |||||||||||||||||||
| Warrant Liability Noncurrent | $67.0K | $127.0K | $83.0K | $71.0K | |||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $6.6M | -$14.8M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $14.3M | $11.7M | $8.8M | $6.4M | $2.3M | $736.0K |
| Proceeds From Stock Options Exercised | $1.0M | $1.4M | $1.4M | $430.0K | $349.0K | $163.0K |
| Payments To Acquire Property Plant And Equipment | $447.0K | $1.3M | $709.0K | $1.1M | $2.1M | $771.0K |
| Net Cash Provided By Used In Operating Activities | -$84.7M | -$79.8M | -$63.8M | -$54.6M | -$32.4M | -$24.3M |
| Net Cash Provided By Used In Investing Activities | $35.6M | $68.8M | -$114.0M | -$67.9M | -$2.1M | -$771.0K |
| Net Cash Provided By Used In Financing Activities | $77.2M | $1.6M | $97.3M | $95.6M | $166.3M | $10.0M |
| Increase Decrease In Prepaid Expenses Other | -$4.0M | $3.9M | -$3.6M | $3.3M | $3.6M | $165.0K |
| Increase Decrease In Accrued Liabilities | $4.1M | $1.6M | $3.3M | $234.0K | $2.2M | -$1.8M |
| Increase Decrease In Accounts Payable | -$846.0K | $482.0K | -$1.0M | $340.0K | $1.1M | -$1.7M |
| Payments To Acquire Marketable Securities | $84.0M | $59.1M | $233.7M | $119.8M | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $120.0M | $129.2M | $120.4M | $53.0M | ||
| Increase Decrease In Other Noncurrent Assets | -$47.0K | $9.0K | $86.0K | $423.0K | ||
| Increase Decrease In Operating Lease Liability | -$1.4M | -$788.0K | -$1.3M | -$744.0K | ||
| Proceeds From Stock Plans | $164.0K | $177.0K | $128.0K | |||
| Proceeds From Issuance Of Common Stock Under At The Market Facility Net Of Issuance Costs | $6.1M | $0.00 | $3.2M | $8.5M | ||
| Proceeds From Issuance Of Common Stock | $46.5M | $0.00 | $86.7M | $78.7M | ||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$186.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $3.5M | $2.9M | $1.9M | $1.6M | $185.0K |
| Proceeds From Stock Options Exercised | $0.00 | $158.0K | $145.0K | $17.0K | $265.0K |
| Payments To Acquire Property Plant And Equipment | $187.0K | $88.0K | $109.0K | $599.0K | $71.0K |
| Net Cash Provided By Used In Operating Activities | -$23.4M | -$24.5M | -$16.4M | -$15.2M | -$5.1M |
| Net Cash Provided By Used In Investing Activities | $29.8M | $9.4M | -$66.9M | -$25.5M | -$71.0K |
| Net Cash Provided By Used In Financing Activities | $96.0K | $253.0K | $201.0K | $17.0K | $87.5M |
| Increase Decrease In Prepaid Expenses Other | -$3.0M | $3.8M | -$2.3M | $1.7M | -$15.0K |
| Increase Decrease In Accrued Liabilities | -$2.5M | -$2.9M | -$506.0K | -$1.8M | -$287.0K |
| Increase Decrease In Accounts Payable | -$298.0K | $23.0K | -$1.9M | -$757.0K | $700.0K |
| Payments To Acquire Marketable Securities | $0.00 | $29.2M | $88.8M | $24.9M | |
| Proceeds From Sale And Maturity Of Marketable Securities | $30.0M | $0.00 | $22.1M | ||
| Increase Decrease In Other Noncurrent Assets | -$518.0K | -$56.0K | $200.0K | ||
| Increase Decrease In Operating Lease Liability | -$325.0K | -$237.0K | -$219.0K | ||
| Proceeds From Stock Plans | $96.0K | $95.0K | $56.0K | ||
| Proceeds From Issuance Of Common Stock Under At The Market Facility Net Of Issuance Costs | |||||
| Proceeds From Issuance Of Common Stock | |||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$21.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.76 | -$1.75 | -$1.93 | -$1.96 | -$8.95 | -$82.06 |
| Weighted Average Number Of Shares Outstanding Basic | 60.3M | 49.7M | 39.6M | 29.9M | 5.2M | |
| Weighted Average Number Of Diluted Shares Outstanding | 60.3M | 49.7M | 39.6M | 29.9M | 5.2M | |
| Earnings Per Share Basic | $-1.76 | $-1.75 | $-1.93 | $-1.96 | $-8.95 | |
| Common Stock Shares Outstanding | 63.6M | 50.0M | 49.4M | 37.8M | 29.2M | 381.1K |
| Common Stock Shares Issued | 63.6M | 50.0M | 49.4M | 37.8M | 29.2M | 381.1K |
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 232.7M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 5.2M | 367.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.40 | -$0.47 | -$0.55 | -$0.42 | -$0.41 | -$0.40 | -$0.48 | -$0.48 | -$0.46 | -$0.54 | -$0.46 | -$0.44 | -$28.33 | -$28.53 | -$20.62 | -$14.81 |
| Weighted Average Number Of Shares Outstanding Basic | 65.9M | 58.0M | 50.1M | 49.7M | 49.5M | 49.5M | 38.2M | 37.9M | 37.8M | 29.3M | 29.3M | 29.2M | 441.4K | 437.5K | ||
| Weighted Average Number Of Diluted Shares Outstanding | 65.9M | 58.0M | 50.1M | 49.7M | 49.5M | 49.5M | 38.2M | 37.9M | 37.8M | 29.3M | 29.3M | 29.2M | 441.4K | 437.5K | ||
| Earnings Per Share Basic | $-0.40 | $-0.47 | $-0.55 | $-0.42 | $-0.41 | $-0.40 | $-0.48 | $-0.48 | $-0.46 | $-0.54 | $-0.46 | $-0.44 | $-28.33 | $-28.53 | ||
| Common Stock Shares Outstanding | 63.0M | 62.1M | 50.2M | 49.8M | 49.6M | 49.5M | 38.2M | 38.1M | 37.8M | 29.3M | 29.3M | 29.2M | 442.7K | |||
| Common Stock Shares Issued | 63.0M | 62.1M | 50.2M | 49.8M | 49.6M | 49.5M | 38.2M | 38.1M | 37.8M | 29.3M | 29.3M | 29.2M | 442.7K | |||
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 470.2M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 29.2M | 441.4K | 400.5K | 376.7K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $14.3M | $11.7M | $8.8M | $6.4M | $2.3M | $736.0K |
| Stock Issued During Period Value Stock Options Exercised | $1.0M | $1.4M | $1.4M | $430.0K | $348.0K | $163.0K |
| Operating Costs And Expenses | $112.8M | $96.1M | $85.0M | $60.3M | $35.3M | $22.2M |
| Depreciation | $1.1M | $1.2M | $1.3M | $1.2M | $831.0K | $831.0K |
| Additional Paid In Capital | $617.4M | $525.9M | $512.6M | $406.6M | $304.5M | $8.2M |
| Capital Expenditures Incurred But Not Yet Paid | $91.0K | $35.0K | $94.0K | $180.0K | $386.0K | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $164.0K | $177.0K | $128.0K | |||
| Fair Value Adjustment Of Warrants | $11.0K | -$3.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $3.7M | $3.8M | $3.5M | $2.8M | $3.1M | $2.9M | $2.3M | $1.9M | $1.9M | $1.7M | $1.3M | $1.6M | $554.0K | $271.0K | $185.0K | $191.0K | $189.0K | $177.0K |
| Stock Issued During Period Value Stock Options Exercised | $1.0M | $2.0K | $634.0K | $83.0K | $158.0K | $202.0K | $660.0K | $145.0K | $104.0K | $309.0K | $17.0K | $20.0K | $20.0K | $265.0K | $18.0K | $97.0K | $33.0K | |
| Operating Costs And Expenses | $27.9M | $28.6M | $29.0M | $23.2M | $22.8M | $22.3M | $20.5M | $20.3M | $19.4M | $16.1M | $13.8M | $12.8M | $8.9M | $8.8M | $5.9M | $3.6M | ||
| Depreciation | $300.0K | $300.0K | $291.0K | $300.0K | $300.0K | $306.0K | $400.0K | $300.0K | $328.0K | $300.0K | $300.0K | $256.0K | $200.0K | $200.0K | $185.0K | $200.0K | ||
| Additional Paid In Capital | $611.5M | $603.3M | $529.6M | $522.5M | $519.0M | $515.8M | $417.0M | $413.3M | $408.7M | $309.5M | $307.7M | $306.1M | $9.5M | |||||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $122.0K | $15.0K | $311.0K | ||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $68.0K | $96.0K | $82.0K | $95.0K | $72.0K | $56.0K | ||||||||||||
| Fair Value Adjustment Of Warrants | -$61.0K | $44.0K | $3.0K | -$4.0K |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 10, 2026.